In our series, patients treated with brachytherapy boost achieved numerically higher biochemical relapse-free survival compared with monotherapy, although this difference did not reach statistical significance, likely reflecting treatment heterogeneity and limited event numbers.
← all excerpts
Permanent seed brachytherapy for prostate cancer: Monotherapy, combined, and salvage approaches remain effective and well-tolerated options.
1
—
—